… To further dissect the relationship between immunogenicity and protection in SARS-CoV-2
we considered the parallels with previous approaches to estimating a ‘50% protective titer’ in …

… neutralizing antibodies are considered linked to protective immunity … antibodies after
vaccination without being able to provide a threshold below which protection against SARS-CoV-2 …

… 1704 infections occurred in the naive cohort, while two … possible (two positive PCR results
90 days apart or an antibody-… first antibody positive test) infections occurred in the SARS-CoV-2…

… of protection from symptomatic infection with a similar virus. Here we extend that work to
show that neutralising antibodies are also highly predictive of protection from SARS-CoV-2 …

… to offer greater resistance to SARS-CoV-2 escape than single antibodies. Our results provide
a … antibodies as candidates for use as COVID-19 immunotherapeutic agents in humans. …

… SARS-CoV-2 S RBD would affect antibody neutralization, we used HIV-1 virus pseudotyped
with the SARS-CoV-2-MA … contributes to optimal protection against SARS-CoV-2 MA in vivo. …

… antibodies (4). Here, we present the isolation of highly potent nAbs to SARS-CoV-2 and
demonstrate their in vivo protective … To investigate the antibody response against SARS-CoV-2 …

… First, comprehensive studies are urgently needed to define clinical correlates of protective
immunity against SARS-CoV-2. Second, because ADE of disease cannot be reliably predicted …

… Although evidence for the primacy of those antibodies for protection will be presented below,
… of the antibody are required for protection against SARS-CoV-2 has been poorly studied. …

… antibody level is a good biomarker for the correlate of protection against SARS-CoV-2 … of
the interaction between the SARS-CoV-2 spike protein and the angiotensin-converting enzyme …